Immunome, Inc. (NASDAQ:IMNM) IPO
IPO
Priced at US$12.00 a share on Oct 1, 2020.
- Price
- US$12.00 a share
- Shares offered
- 3,250,000 shares of common stock
- Offering size
- US$39 million
- Underwriters' option
- Up to 487,500 more shares
- Listing
- IMNM on the Nasdaq Capital Market
- Underwriters
- Ladenburg Thalmann, Chardan · In the order on the cover
- Shares delivered
- On or about Oct 6, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 12, 2020 |
| Filed publicly | Sep 9, 2020 |
| Amended once | Sep 24, 2020 |
| Shares registered with an exchange | Sep 30, 2020 |
| Declared effective by the SEC | Oct 1, 2020 |
| Final prospectus, with the price | Oct 5, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 5, 2020 |
| EFFECT · Notice that a registration is effective | Oct 1, 2020 |
| S-1MEF · Registration of more shares for the same offering | Oct 1, 2020 |
| CERT · Exchange's certificate of listing | Oct 1, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 30, 2020 |
| CORRESP · Letter to the SEC | Sep 29, 2020 |
| CORRESP · Letter to the SEC | Sep 29, 2020 |
| S-1/A · Registration statement, amended | Sep 24, 2020 |
| CORRESP · Letter to the SEC | Sep 9, 2020 |
| S-1 · Registration statement | Sep 9, 2020 |
| UPLOAD · Letter from the SEC | Sep 1, 2020 |
| DRS · Draft registration statement | Aug 12, 2020 |
From the cover of the final prospectus (424B4) filed Oct 5, 2020